BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 6381211)

  • 1. [Immunostimulation with inactivated Candida albicans and chemotherapy in murine lymphoma].
    Tissi L; Scaringi L; Cassone A; D'Errico P; Marconi P
    G Ital Chemioter; 1984; 31(1-2):91-100. PubMed ID: 6381211
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immune response to a histocompatible murine lymphoma. Synergism with chemotherapy].
    Scaringi L; Tissi L; Cassone A; Boccanera M; Marconi P
    G Ital Chemioter; 1984; 31(1-2):81-90. PubMed ID: 6381210
    [No Abstract]   [Full Text] [Related]  

  • 3. [Further study of immunopotentiation in experimental antiblastic therapy by inactivated yeasts and glucan].
    Delfina Pesce C; Boccanera M; Marconi P; Bistoni F; Cenci E; Tissi L; Cassone A
    Ann Ist Super Sanita; 1982; 18(3):509-12. PubMed ID: 7187836
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro studies of the interaction of murine phagocytic cells with Candida albicans.
    Morrison RP; Cutler JE
    J Reticuloendothel Soc; 1981 Jan; 29(1):23-34. PubMed ID: 7009855
    [No Abstract]   [Full Text] [Related]  

  • 5. CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance.
    Romani L; Mencacci A; Cenci E; Spaccapelo R; Mosci P; Puccetti P; Bistoni F
    J Immunol; 1993 Feb; 150(3):925-31. PubMed ID: 8093707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of BCG or Candida albicans (CA) with antitumor agents against a virus-induced lymphoma in mice.
    Bistoni F; Marconi P; Pitzurra M; Frati L; Spreafico F; Goldin A; Bonmassar E
    Eur J Cancer (1965); 1979 Nov; 15(11):1305-14. PubMed ID: 393515
    [No Abstract]   [Full Text] [Related]  

  • 7. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
    Han Y; Ulrich MA; Cutler JE
    J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing and treatment with Candida albicans.
    Hosen H
    Ann Allergy; 1988 Nov; 61(5):405. PubMed ID: 3056126
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphokine-activated killer (LAK)-like cells induced in mice after repeated intraperitoneal injections of inactivated Candida albicans.
    Scaringi L; Rosati M; Bistoni F; Cassone A; Marconi P
    J Chemother; 1989 Jul; 1(4 Suppl):446-8. PubMed ID: 16312479
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment with antifungal vaccines.
    Beemer AM; Kuttin ES; Pinto M
    Contrib Microbiol Immunol; 1977; 4():136-46. PubMed ID: 342190
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationships among tumor load, route of tumor inoculation, and response to immunochemotherapy in a murine lymphoma model.
    Marconi P; Cassone A; Baccarini M; Tissi L; Garaci E; Bonmassar E; Frati L; Bistoni F
    J Natl Cancer Inst; 1983 Aug; 71(2):299-307. PubMed ID: 6348362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined effects of chemotherapy and host antitumor response in a murine histocompatible lymphoma model.
    Marconi P; Scaringi L; Tissi L; Puccetti P; Cassone A
    Int J Immunopharmacol; 1984; 6(3):217-22. PubMed ID: 6378809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological features of murine systemic vasculitis caused by Candida albicans extract--an animal model of Kawasaki disease.
    Takahashi K; Oharaseki T; Wakayama M; Yokouchi Y; Naoe S; Murata H
    Inflamm Res; 2004 Feb; 53(2):72-7. PubMed ID: 15021972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of BCG as an immunoadjuvant in combination with antitumor agents in virus-induced leukemia].
    Sbaraglia G; Cenci E; Vecchiarelli A; Perito S
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1969-75. PubMed ID: 7459108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep and temperature responses of inbred mice with Candida albicans-induced pyelonephritis.
    Toth LA; Hughes LF
    Comp Med; 2006 Aug; 56(4):252-61. PubMed ID: 16941952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular mechanisms underlying the adjuvant activity of Candida albicans in a mouse lymphoma model.
    Marconi P; Cassone A; Tissi L; Baccarini M; Puccetti P; Garaci E; Bonmassar E; Bistoni F
    Int J Cancer; 1982 Apr; 29(4):483-8. PubMed ID: 7044994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local and systemic immune response to inactivated Candida albicans in mice.
    Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P
    Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of anti-Candida antibodies in mice with gut colonization of Candida albicans.
    Tansho S; Abe S; Ishibashi H; Mitsuya M; Wada K; Ikeda T; Suegara N; Koshio O; Ono Y; Yamaguchi H
    Mediators Inflamm; 2004 Jun; 13(3):189-93. PubMed ID: 15223610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice.
    Hida S; Miura NN; Adachi Y; Ohno N
    J Autoimmun; 2005 Sep; 25(2):93-101. PubMed ID: 16242302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoproteomic analysis of the protective response obtained from vaccination with Candida albicans ecm33 cell wall mutant in mice.
    Martínez-López R; Nombela C; Diez-Orejas R; Monteoliva L; Gil C
    Proteomics; 2008 Jul; 8(13):2651-64. PubMed ID: 18546157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.